Clinical Trials Search at Vanderbilt-Ingram Cancer Center
A Pivotal Trial of Envafolimab, and Envafolimab in Combination with Ipilimumab, in Patients with Advanced or Metastatic Undifferentiated Pleomorphic Sarcoma or Myxofibrosarcoma Who Have Progressed on Prior Chemotherapy
Sarcoma
Sarcoma
Sarcoma
II
Keedy, Vicki
NCT04480502
VICCSAR2076
The Effects of Virtual Reality on Pain, Stress, and Affect in the Infusion Clinic
Supportive Care
Supportive Care
Supportive Care
N/A
Stansel, Cody
NCT05135260
VICCSUPP2079
Preserving Fertility After Colorectal Cancer: The PREFACE Study
Multiple Cancer Types
Colon,
Rectal
N/A
Holowatyj, Andreana
NCT05239338
VICCGI2186
A Randomized, Double-Blind, Phase III Study Comparing NIS793 in Combination with Gemcitabine and Nab-Paclitaxel versus Placebo Combined with Gemcitabine and Nab-Paclitaxel for First Line Treatment of Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
Pancreatic
Pancreatic
Pancreatic
III
Cardin, Dana
NCT04935359
VICCGI2187
Vertebral Bone Marrow in Lung Cancer Attention Trial (VMAT)
Lung
Lung
Lung
N/A
Osmundson, Evan
NCT05248256
VICCRAD2189
Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for the Treatment of Bone Marrow Failure Diseases
Multiple Cancer Types
Hematologic,
Pediatrics
II
Connelly, James
NCT04965597
VICCPED2192
A Phase 3 Randomized Study Comparing Teclistamab in Combination with Daratumumab SC (Tec-Dara) versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants with Relapsed or Refractory Multiple Myeloma.
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
III
Sengsayadeth, Salyka
NCT05083169
VICCPCL2194
A Phase 1 First-In-Human Dose-Escalation and Dose-Expansion Study of BMF-219, an Oral Irreversible Menin Inhibitor, in Adult Patients with Acute Leukemia (AL), diffuse large B-cell lymphoma (DLBCL), and multiple myeloma (MM)
Multiple Cancer Types
Leukemia,
Phase I
I
Kishtagari, Ashwin
NCT05153330
VICCHEMP2195
Randomized Phase II Trial of Lutetium Lu 177 Dotatate Versus Everolimus in Somatostatin Receptor Positive Bronchial Neuroendocrine Tumors.
Lung
Lung
Lung
II
Ramirez, Robert
NCT04665739
SWOGTHOA021901
A Randomized Phase 2 Study of combination Atezolizumab and CDX-1127 (Varlilumab) with or without Addition of Cobimetinib in previously treated Unresectable Biliary Tract Cancers.
Liver
Liver
Liver
II
Goff, Laura
NCT04941287
VICCNCIGI10476
